Association of human papillomavirus-related knowledge, attitudes, and beliefs with HIV status: A national study of gay men

Journal of Lower Genital Tract Disease

Volumn 15, Issue 2, 2011, Pages 83-88

  Gilbert, Paul A ^a   Brewer, Noel T ^a,b   Reiter, Paul L ^a,b  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

acceptability; gay men; human papillomavirus; vaccine

Indexed keywords

WART VIRUS VACCINE;

ADULT; ANUS CANCER; ARTICLE; ATTITUDE TO HEALTH; CANCER RISK; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; DISEASE ASSOCIATION; HEALTH BELIEF; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; PAPILLOMAVIRUS INFECTION; PROPHYLAXIS; VACCINATION; WART VIRUS;

ADULT; ANUS NEOPLASMS; CONDYLOMATA ACUMINATA; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; UNITED STATES;

EID: 79955052629     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/LGT.0b013e3181f1a960     Document Type: Article

References (25)

1. de Pokomandy A, Rouleau D, Ghattas G, Vezina S, Cote P, Macleod J, et al. Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study. J Infect Dis 2009;199:965-73.
2. Steben M, Duarte-Franco E. Human papillomavirus infection: epidemiology and pathophysiology. Gynecol Oncol 2007;107(2 suppl 1):S2-5. (Pubitemid 47559075)
3. Palefsky J. Human papillomavirus and anal neoplasia. Curr HIV/AIDS Rep 2008;5:78-85. (Pubitemid 351656421)
4. Chin-Hong PV, Vittinghoff E, Cranston RD, Browne L, Buchbinder S, Colfax G, et al. Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study. J Natl Cancer Inst 2005;97:896-905. (Pubitemid 41417941)
5. Palefsky JM, Holly EA, Ralston ML, Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)- positive and HIV-negative homosexual men. J Infect Dis 1998;177:361-7. (Pubitemid 28063760)
6. Palefsky JM, Holly EA, Ralston ML, Jay N, Berry JM, Darragh TM. High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. AIDS 1998;12:495-503. (Pubitemid 28116159)
7. McQuillan GM, Kruszon-Moran D, Granade T, Feldman JW. Seroprevalence of human immunodeficiency virus in the US household population aged 18-49 years: the National Health and Nutrition Examination Surveys, 1999-2006. J Acquir Immune Defic Syndr 2009;53:117-23.
8. Gayle H. An overview of the global HIV/AIDS epidemic, with a focus on the United States. AIDS 2000;14(suppl 2):S8-17.
9. Palefsky J. Human papillomavirus-related disease in people with HIV. Curr Opin HIV AIDS 2009;4:52-6.
10. Kojic EM, Cu-Uvin S. Update: human papillomavirus infection remains highly prevalent and persistent among HIV-infected individuals. Curr Opin Oncol 2007;19:464-9. (Pubitemid 47356603)
11. Reed AC, Reiter PL, Smith JS, Palefsky JM, Brewer NT. Gay and bisexual men's willingness to receive anal Papanico-laou testing. Am J Public Health 2010;100:1123-9.
12. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56(RR-2):1-24.
13. Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 2008;113(suppl 10): 3036-46.
14. Giuliano AR, Salmon D. The case for a gender-neutral (universal) human papillomavirus vaccination policy in the United States: Point. Cancer Epidemiol Biomarkers Prev 2008; 17:805-8.
15. Bush M. HPV vaccine for MSM. Aust Nurs J 2008; 16:33.
16. Giuliano AR. Human papillomavirus vaccination in males. Gynecol Oncol 2007;107(2 suppl 1):S24-6. (Pubitemid 47559076)
17. Singer N. Vaccine against virus in girls may be given to boys. The New York Times. 2009;Sect. 1.
18. Markowitz LE, Sternberg M, Dunne EF, McQuillan G, Unger ER. Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004. J Infect Dis 2009; 200:1059-67.
19. Baker L, Bundorf M, Singer S, Wagner T. Validity of the Survey of Health and the Internet and Knowledge Network's Panel and Sampling; 2003. www.cdc.gov/pcd/issues/2004/oct/pdf/04-0004-01.pdf. Accessed July 30, 2010.
20. McRee AL, Brewer NT, Reiter PL, Gottlieb SL, Smith JS. The Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS): scale development and associations with intentions to vaccinate. Sex Transm Dis 2009;37:234-9.
21. Reiter PL, Brewer NT, Gottlieb SL, McRee AL, Smith JS. Parents' health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med 2009;69:475-80.
22. Palefsky J, Giuliano AR, on behalf of the Male Quadrivalent HPV Vaccine Efficacy Trial Study Group. Efficacy of the Quadrivalent HPV Vaccine Against HPV 6/11/16/18- Related Genital Infection in Young Men. Nice, France: European Research Organization on Genital Infection and Neoplasia (EUROGIN); 2008:2008.
23. Liddon N, Hood J, Wynn BA, Markowitz LE. Acceptability of human papillomavirus vaccine for males: a review of the literature. J Adolesc Health 2010;46:113-23.
24. Marra F, Cloutier K, Oteng B, Marra C, Ogilvie G. Effectiveness and cost effectiveness of human papillomavirus vaccine: a systematic review. Pharmacoeconomics 2009;27:127-47.
25. Kim JJ, Goldie SJ. Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States. BMJ 2009;339:b3884.